NDC 69117-0018-01 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69117-0018
- Requested NDC
- 69117-0018-01
- Package NDCs from labels
- 69117-0018-1, 69117-0018-2, 69117-0018-01
- Manufacturer
- YILING PHARMACEUTICAL, INC. | YILING PHARMACEUTICAL LTD
- Effective date
- 2025-12-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir - YILING PHARMACEUTICAL, INC. | YILING PHARMACEUTICAL LTD | YILING PHARMACEUTICAL, INC. | YILING PHARMACEUTICAL LTD | 2025-12-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - Proficient Rx LP | Proficient Rx LP | 2024-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - RPK Pharmaceuticals, Inc. | RPK Pharmaceuticals, Inc. | 2022-03-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - Bryant Ranch Prepack | Bryant Ranch Prepack | 2022-02-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - Bryant Ranch Prepack | Bryant Ranch Prepack | 2022-02-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - Bryant Ranch Prepack | Bryant Ranch Prepack | 2022-02-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - REMEDYREPACK INC. | REMEDYREPACK INC. | 2021-06-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2021-02-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2021-02-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2020-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Acyclovir - REMEDYREPACK INC. | REMEDYREPACK INC. | 2019-09-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69117-0018-1 | Acyclovir | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 69117-0018-2 | Acyclovir | 500 in 1 BOTTLE | TABLET | 500 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69117-0018 | ACYCLOVIR TABLET [YILING PHARMACEUTICAL, INC.] | 8 | Current NDC, Legacy NDC, 2 package rows | 20250101_677edfd5-2d04-b932-e053-2a91aa0a26b0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69117-0018-1 | EA - Each | 69117-0018 | 6e50aa43-459d-4c85-b38b-71f8aadadd36 | 1 | 2018-09-05 |
| 69117-0018-2 | EA - Each | 69117-0018 | a8aa51bf-b186-4f0d-833f-47393834f596 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | e4f91376-9e18-41a4-aa5e-adcea0c625d9 | 2023-12-05 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bionpharma Inc. | 6f1db9f0-9b41-4fb7-8798-44fdc2c128df | 2023-12-03 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir suspension | ACYCLOVIR | Novadoz Pharmaceuticals LLC | 3efa1e5e-5a14-4724-a2ca-25702f10faed | 2023-11-03 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | 942632d8-08cd-4003-aec0-1c6d5c09bc15 | 2023-07-24 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | SQUARE PHARMACEUTICALS LIMITED | b24201ea-aeae-4de1-b01b-eee89068e786 | 2023-07-02 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | e8433261-07f1-448b-aaf4-631414598c08 | 2023-05-08 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | c40a57b9-4cf1-4a69-abf3-eb99a7fcda00 | 2023-04-16 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| 2e3ccb1c-3e5e-4845-b780-2a7b0fd078b8 | 1e1ab04a-ed67-4b12-a671-92b86ac9153e | 2023-03-20 | Warnings, Adverse reactions | 1e1ab04a-ed67-4b12-a671-92b86ac9153e | ||
| e4ca0843-7d51-4d81-ae68-b85f3965a3e1 | ea778f5c-6b11-4245-9ca4-3fd8c4e0c962 | 2023-03-20 | Warnings, Adverse reactions | ea778f5c-6b11-4245-9ca4-3fd8c4e0c962 | ||
| f626bd20-12a0-4ed8-993a-2e46d071e1a4 | 9169d63d-a8fc-461d-9f66-27b3e4db3237 | 2023-03-20 | Warnings, Adverse reactions | 9169d63d-a8fc-461d-9f66-27b3e4db3237 | ||
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | 34a38cdf-04e8-4006-a9f5-4a0831117d61 | 2023-02-06 | Warnings, Adverse reactions | X4HES1O11F |
| f14d39ab-9fca-03ba-e053-2995a90a2360 | 95fbf4c2-c97e-2d41-e053-2995a90a0d54 | 2023-01-02 | Warnings, Adverse reactions | 95fbf4c2-c97e-2d41-e053-2995a90a0d54 | ||
| Acyclovir | ACYCLOVIR | Modavar Pharmaceuticals LLC | 8de9c4f3-b800-4419-a063-8b62a0cba0fa | 2022-12-29 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Quinn Pharmaceuticals | 9ad711e4-003d-4b58-8177-32928bc42aa9 | 2022-12-20 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | PharmPak, Inc. | d824fc07-9f03-4cb2-9bf8-ff7cc2955255 | 2022-10-09 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | PharmPak, Inc. | 8fb01f23-e2bd-6850-e053-2995a90a7cc5 | 2022-10-09 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | Viona Pharmaceuticals Inc | 12df1991-fb1c-45df-acf3-706b1e8ecfc3 | 2022-10-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Camber Pharmaceuticals, Inc. | 2ca1395f-96b4-4543-8eed-bd07c62bbc7c | 2022-09-12 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | e8056ec6-d2dc-48af-8550-82726af1c5c5 | 2022-08-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | 9e5b3a11-9c4b-4998-8a18-3046af1314ab | 2022-06-01 | Warnings, Adverse reactions | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.